At a glance
ClinicalIndex Comparison RecordN/ACompleted· 165 enrolled
Drug / intervention
enVista MX60EFH trifocal intraocular lenses (IOLs) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicenter, Randomized, Masked, Controlled Clinical Study to Evaluate the Safety and Performance of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction
In Brief
A clinical study evaluating enVista MX60EFH trifocal intraocular lenses (IOLs) and enVista MX60E monofocal intraocular lenses (IOLs) for Cataract. Completed, enrolled 165 participants across 9 sites.
Detailed Summary
The objective of the study is to evaluate the safety and performance of the enVista trifocal intraocular lens when implanted in the capsular bag.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartMar 2020
Primary CompletionJun 2022
TodayJul 2026
First PostedJan 13, 2020
Enrollment StartMar 10, 2020
Primary CompletionJun 14, 2022
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 6.5 years ago
Interventions
enVista MX60EFH trifocal intraocular lenses (IOLs)device
enVista MX60EFH trifocal intraocular lenses (IOLs) implanted bilaterally
enVista MX60E monofocal intraocular lenses (IOLs)device
enVista MX60E monofocal intraocular lenses (IOLs) implanted bilaterally